ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 830
    Calcinosis Is Associated with Digital Ulcers and Osteoporosis in Patients with Systemic Sclerosis
  • Abstract Number: 1894
    Calcium Channel Blockers Are More Effective in the Treatment of Primary Raynaud’s Phenomenon Compared to Secondary: A Meta-Analyis
  • Abstract Number: 215
    Calcium Hydroxyapatite Crystals Inhibit Interleukin-6- and Interferon-γ –Induced Anti-Osteoclastogenic Signaling in Human Osteoclast Precursors
  • Abstract Number: 3164
    Calcium Pyrophosphate Deposition Disease and Associated Medical Co-Morbidities in the Veteran Population
  • Abstract Number: 330
    Calf Muscle Adiposity Is Associated with Impaired Physical Performance in Knee OA
  • Abstract Number: 549
    Calprotectin (MRP8/MRP14), a Major Leukocyte Protein, Is Highly Associated to Ultrasound Detected Synovitis and Is Responsive to Biologic Treatment
  • Abstract Number: 604
    Calprotectin and TNF Antagonist Serum Trough Levels Identify Active Ultrasound Synovitis in Rheumatoid Arhritis and Psoriatic Arthritis Patients in Remission or Low Disease Activity
  • Abstract Number: 991
    CaMK4 Facilitates Recruitment of IL-17 Producing Cells to Target Organs through the CCR6/CCL20 Axis in Th17-Driven Inflammatory Diseases
  • Abstract Number: 550
    Can Anti-TNF-Induced Autoantibody Conversion be Reversed By Switching to Abatacept Therapy in Patients with RA on Background MTX?
  • Abstract Number: 1299
    Can Bone Marrow Lesions be Scored More Reliably and Responsively in Knee Osteoarthritis Using a Web-Based Overlay System (KIMRISS) Than By Standard MRI Osteoarthritis Knee Scoring (MOAKS)?  Data from the Osteoarthritis Initiative and a Prospective Trial of Adaluminab Therapy
  • Abstract Number: 630
    Can Extraglandular Manifestations Differentiate Primary Sjögren’s Syndrome from Sjögren’s-Systemic Lupus Erythematosus Overlap Syndrome?
  • Abstract Number: 2906
    Can Immunosuppressive Drug Treatment Reduce Mortality in Patients with Systemic Lupus Erythematosus (SLE): A Propensity Score Analysis of a Longitudinal Cohort of 803 Patients?
  • Abstract Number: 1490
    Can Patients Forget Their Artificial Joint after Arthroplasty?
  • Abstract Number: 1719
    Can Structural Progression on MRI of Sacroiliac Joints in Patients with Spondyloarthritis be Reliably Detected and What Type of Calibration Is Necessary to Achieve This?
  • Abstract Number: 2234
    Can the Fracture Risk Assessment Tool (FRAX) Also Predict Falls in Older Women?
  • Abstract Number: 662
    Can the New Contest Questionnaire Identify Psoriatic Arthritis in a Primary Care Population?
  • Abstract Number: 3057
    Can We Differentiate Takayasu’s Arteritis from Atherosclerosis Using Carotid Artery Doppler Usg?
  • Abstract Number: 2347
    Can We Predict the Dose of Allopurinol to Achieve Target Urate?
  • Abstract Number: 1969
    Can We Predict the Relapse of Giant Cell Arteritis?
  • Abstract Number: 365
    Can We Use Bone Turnover Markers As Targets for Antiresorptive Treatment in Postmenopausal Osteoporosis? an Analysis from Two Phase 3 Clinical Trials
  • Abstract Number: 2345
    Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Long-Term Safety and Efficacy Results from a 36-Week Extension Study
  • Abstract Number: 262
    Canakinumab Therapy in Patients with Familial Mediterranean Fever
  • Abstract Number: 290
    Cancer and Necrotizing Immune Mopathy: High Incidence in Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Positive and Seronegative Patients but Not in Anti-Single Recognition Particle Positive Patients
  • Abstract Number: 955
    Cancer Risk in 5,108 Patients with Juvenile Idiopathic Arthritis (JIA)
  • Abstract Number: 2255
    Capillaroscopic Patterns in a Healthy Population
  • Abstract Number: 3103
    Carbamylated Human Albumin Is One of the Target Antigens of Anti-Carbamylated Protein Antibodies
  • Abstract Number: 1581
    Cardiac Involvement in Patients with Amyloid a Amyloidosis Due to Rheumatoid Arthritis
  • Abstract Number: 2586
    Cardiac Magnetic Resonance Imaging Reveals Myocardial Damage in Patients with Active Rheumatoid Arthritis
  • Abstract Number: 3064
    Cardiac Manifestation of  Takayasu  Arteritis
  • Abstract Number: 1568
    Cardiac Morphology and Function in Patients with Acute Coronary Syndrome Complicated with Rheumatoid Arthritis
  • Abstract Number: 2972
    Cardiopulmonary Exercise Testing in Patients with Systemic Sclerosis: Unexplored Mechanisms of Dyspnea
  • Abstract Number: 1972
    Cardiovascular and Cerebrovascular Disease and Social Deprivation in Patients with Giant Cell Arteritis
  • Abstract Number: 1604
    Cardiovascular Disease in a Large Incident Cohort of Early Inflammatory Arthritis
  • Abstract Number: 37
    Cardiovascular Disease in Immune-Mediated Inflammatory Diseases: Cross Sectional Analysis of the Influence of Demographic and Traditional Cardiovascular Risk Factors
  • Abstract Number: 2270
    Cardiovascular Disease: The Hidden Risk in Persons with Rheumatoid Arthritis
  • Abstract Number: 2578
    Cardiovascular Effects of Etanercept in an Animal Model of Rheumatoid Arthritis: Mechanisms Involved
  • Abstract Number: 1540
    Cardiovascular Risk Management in Rheumatoid Arthritis Patients
  • Abstract Number: 1505
    Carotid Artery Atherosclerosis in Patients with Active Rheumatoid Arthritis: Predictors of Plaque Occurrence and Progression over 24 Weeks
  • Abstract Number: 300
    Causes of Creatine Kinase Levels Greater Than 1,000 IU/L in Patients Referred to Rheumatology
  • Abstract Number: 1876
    Caveolin 1 Gene Variants May Effect Disease Progression in Systemic Sclerosis Related Interstitial Lung Disease
  • Abstract Number: 2009
    CC-Chemokine Receptor 7 (CCR7) Deficiency Reduces Early Structural and Functional Features of Disease in a Murine Model of Osteoarthritis
  • Abstract Number: 2602
    CCP Antibody Negativity Is Associated with Higher Fatigue in Rheumatoid Arthritis
  • Abstract Number: 1070
    CD 14(C-159T) Polymorphism and Soluble CD14 Are Associated with Increased Disease Activity and Nephritis in SLE
  • Abstract Number: 10
    CD13/Aminopeptidase N Contributes to Angiogenesis and Monocyte Chemotaxis in Rheumatoid Arthritis
  • Abstract Number: 794
    CD163+ Macrophages Display Mixed Polarizations in Discoid Lupus Skin
  • Abstract Number: 1102
    CD19+CD24-CD38hi B-Cell Subset: A Potential Biomarker for IgG4-Related Disease
  • Abstract Number: 3028
    CD1d Regulates iNKT Cell Autoreactivity
  • Abstract Number: 982
    CD4+CD146+ T Cells: The Primed IL-17 Secreting Cells in the Pathogenesis of Psoriatic Arthritis
  • Abstract Number: 1370
    CD40/CD40L Pathway Is Associated with Increased Oxidative Burst and Neutrophil Extracellular Traps Release in Behcet´s Disease
  • Abstract Number: 3087
    Cell Bound Complement Activation Products in Multianalyte Assay with Algorithm Have Utility in Distinguishing Primary Fibromyalgia from Systemic Lupus Erythematosus
  • Abstract Number: 719
    Cell of Origin of Diffuse Large B-Cell Lymphoma (DLBCL) in Patients with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 818
    Cell-Bound Complement Activation Products (CB-CAP) Profiles in Patients with Pre-Systemic Lupus Erythematosus
  • Abstract Number: 2043
    Cell-Bound Complement Activation Products Have High Sensitivity and Specificity in Childhood-Onset Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis
  • Abstract Number: 3006
    Cell-Free Circulating DNA in Systemic Sclerosis: Increased Levels and Global Cytosine Hypomethylation
  • Abstract Number: 889
    Central Nervous System Involvement of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss): Retrospective Analysis of 26 Cases and Review of the Literature
  • Abstract Number: 1435
    Central Pain Sensitization in Rheumatoid Arthritis – Role of ACPA?
  • Abstract Number: 968
    Certolizumab Pegol in Combination with Methotrexate in DMARD-Naïve Patients with Active, Severe, Progressive Rheumatoid Arthritis: Results from a Randomized, Double-Blind, Controlled Phase 3 Study
  • Abstract Number: 903
    CGEN-15001, a Novel B7-like Protein, Controls Inflammation in a Translational Rheumatoid Arthritis (RA) Assay and Induces Treg Driven Long-Term Remission in an Autoimmune Disease Model
  • Abstract Number: 449
    Change from SC to IV Abatacept and Back in Patients with Rheumatoid Arthritis As Simulation of a Vacation: A Prospective Phase IV, Open Label Trial (A-BREAK)
  • Abstract Number: 1331
    Change in MRI in Patients with Spondyloarthritis Treated with Anti-TNF Agents : Systematic Review of the Literature
  • Abstract Number: 501
    Change in RF Titers Reflects RA Disease Activity and Predicts Therapeutic Response during TNF Inhibitor Therapy; Patients with a Continuous Reduction of Serum RF Levels Show Good Response
  • Abstract Number: 1007
    Change in Semi-Quantitative Imaging Biomarkers Predicts Knee Osteoarthritis Progression: Data from the Fnih OA Biomarkers Consortium
  • Abstract Number: 707
    Change of Enthesial Involvement Under Treatment Was Independent from the Therapeutic Strategy in Patients with Axial Spondyloarthritis within the Scqm Cohort
  • Abstract Number: 2615
    Changes in a Patient-Reported Measure of Physical Function, PF-10a, Are Most Strongly Associated with Changes in the Patient Global Assessment Portion of a Composite Measure of RA Disease Activity
  • Abstract Number: 460
    Changes in Body Composition and Metabolic Profile during Treatment with Tocilizumab in Patients with Rheumatoid Arthritis
  • Abstract Number: 2645
    Changes in Clinical Disease Activity Index and Changes in Sleep Among RA Patients Initiating Disease Modifying Antirheumatic Drugs
  • Abstract Number: 1363
    Changes in Cyclooxygenase-2’s Expression, and PGE2’s and 6-Keto-PGF1α Levels in the Presence of the Muscarinic Acethylcholine Receptor Antibody in Primary Sjogren Syndrome
  • Abstract Number: 745
    Changes in Serum Albumin Levels Correlate Highly with Severity and Activity of SLE
  • Abstract Number: 2841
    Changes in Treatment Patterns in Psoriatic Arthritis Patients Newly Initiated on Biologic and Non-Biologic Therapy Enrolled in a North American Clinical Registry
  • Abstract Number: 2032
    Chaperonin Protein 14-3-3eta, Cyclic Citrullinated Peptide Antibody, and Rheumatoid Factor in the Differential Diagnosis of Chikungunya Arthritis Versus Rheumatoid Arthritis
  • Abstract Number: 527
    Characterisation of the Antibody Response to a Citrullinated Peptide – Derived from the Porphyromonas Gingivalis Peptidyl Arginine Deiminase Enzyme – in Patients with Rheumatoid Arthritis
  • Abstract Number: 50
    Characteristics and Outcomes Associated with Early Corticosteroid Use in a Large Multicenter Canadian RA Cohort
  • Abstract Number: 2523
    Characteristics and Outcomes of Prospectively-Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database
  • Abstract Number: 1221
    Characteristics and Outcomes of RA Patients Who Start Biosimilar Infliximab in South Korea
  • Abstract Number: 1090
    Characteristics and Trajectories of Child Pain, Function, and Psychological Outcomes Associated with Conversion Disorder in Intensive Interdisciplinary Pediatric Pain Rehabilitation
  • Abstract Number: 2621
    Characteristics of Histopathology and Clinical Course of 19 Cases That Developed a Lymphoproliferative Disease (LPD) during Methotrexate (MTX) Treatment.
  • Abstract Number: 149
    Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus (SLE) Initiating Treatment with Belimumab in a US Commercially Insured Database: 2010-2014
  • Abstract Number: 410
    Characteristics of the Juvenile Systemic Sclerosis Cohort within the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
  • Abstract Number: 1779
    Characterization of Anti-Nuclear Antibody (ANA) Signatures in Murine Models of Lupus Using Genalyte Maverick Technology
  • Abstract Number: 1047
    Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in Two Phase 3 Studies
  • Abstract Number: 1177
    Characterization of Different Phosphorylation Sites of Mcl-1 in Human Rheumatoid Arthritis Synovial Fibroblasts and Their Correlation with RA Pathogenesis
  • Abstract Number: 3200
    Characterization of Early and Progressive Autoimmunity in Sjogrens Syndrome: The Incomplete Sjogrens Syndrome Model
  • Abstract Number: 1752
    Characterization of Epitopes Identified with Cerebral Vasculature Injury
  • Abstract Number: 2832
    Characterization of Leukocyte Subsets in Ankylosing Spondylitis Patients
  • Abstract Number: 1380
    Characterization of Lymphocytes Subsets in Peripheral Blood of Untreated IgG4-Related Disease Patients
  • Abstract Number: 2825
    Characterization of Mesenchymal Stem Cells Generated from Axial Spondyloarthritis Patient-Derived Induced Pluripotent Stem Cells
  • Abstract Number: 1436
    Characterization of Patient Reported Pain Medication in Early Vs. Established Rheumatoid Arthritis
  • Abstract Number: 408
    Characterization of Pediatric Systemic Lupus Erythematosus with Acquired Angioedema
  • Abstract Number: 673
    Characterization of Psoriatic Arthritis [Psa] in a Large, Integrated Health Plan: Demographics, Referral Patterns and Care Management
  • Abstract Number: 1372
    Characterization of Synovial Mast Cells in Knee Osteoarthritis: Association with Clinical Parameters
  • Abstract Number: 3015
    Characterization of the Profibrotic/Antifibrotic Profile of microRNA Contained in Exosomes Isolated from Cultured Normal Human Dermal and Lung Microvascular Endothelial Cells Undergoing Endothelial Mesenchymal Transition in Vitro
  • Abstract Number: 2464
    Characterization of the Serum Anti-Citrullinated Protein Antibody Profile in Juvenile Idiopathic Arthritis: Association with Oral Health
  • Abstract Number: 3022
    Characterizing a Novel Gene, Mosaic, and Its Role in Mediating a Multisystem Autoimmunity
  • Abstract Number: 3212
    Characterizing the Effects of the G-CSF-R Coding rs13377964 SNP Located within Murine Lupus Susceptibility Locus Sle2c2
  • Abstract Number: 2549
    Characterizing the RPTPσ Mediated Proteoglycan Switch As a Target for Rheumatoid Arthritis Therapy
  • Abstract Number: 1069
    Child’s HLA-DRB1 Genotype Increases Maternal Risk of Systemic Lupus Erythematosus: Results from the Mother-Child Immunogenetic Study in Autoimmunity
  • Abstract Number: 3072
    Childhood Takayasu Arteritis. a Single Center Experience
  • Abstract Number: 2482
    Choosing Subserologies More Wisely:  Implementing Anti-Nuclear Antibody (ANA) Reflex Testing and Education to Reduce Unnecessary Costs in an Integrated Healthcare System
  • Abstract Number: 386
    Chronic Arthritis in Systemic Lupus Erythematosus: Distinct Features in 336 Pediatric and 1,830 Adult Patients
  • Abstract Number: 917
    Chronic Widespread Pain in Adolescents Is Highly Associated to Stress and Anxiety
  • Abstract Number: 3236
    Circulating Cytokine/Chemokine Concentrations Predict Cancer Mortality in Men with Rheumatoid Arthritis
  • Abstract Number: 817
    Circulating Endothelial Cell (CEC) and CEC-Bound C4d Levels As Biomarkers of Systemic Lupus Erythematosus
  • Abstract Number: 770
    Circulating Levels of iC3b and C3 Correlate with Sledai-2K Responder Index-50 (S2K RI-50) Disease Activity Scores: The Castle (Complement Activation Signatures in Systemic Lupus Erythematosus) Study
  • Abstract Number: 217
    Circulating Levels of Neo-Epitopes Reflecting Connective Tissue Turnover As Biomarkers of Gout and Frequent Gout Attacks in Men
  • Abstract Number: 3195
    Circulating Micro-RNA Profiles in Responders to Adalimumab Plus Methotrexate Versus Methotrexate Alone: A Placebo-Controlled Clinical Trial
  • Abstract Number: 1880
    Circulating Microparticle Populations May Differentiate Between Connective Tissue Diseases. 
  • Abstract Number: 2005
    Circulating Mirnas As Potential Disease Biomarkers in Antiphospholipid Syndrome Patients
  • Abstract Number: 2611
    Circulating Monocyte Count Is Significantly Associated with Interstitial Pneumonia in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Cohort Study (Keio First-Bio Cohort Study)
  • Abstract Number: 1100
    Citrullinated Antigen-Specific B Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis: Identification and Phenotypic Characterization
  • Abstract Number: 905
    Citrullinated Epithelial-Derived Neutrophil-Activating Peptide 78 (ENA-78/CXCL5) Induces Monocyte Migration Via JNK and NFκB Signaling Pathways
  • Abstract Number: 526
    Citrullinated Fibrinogen Promotes Bone Marrow Mesenchymal Stem Cells to Assume a Proinflammatory Phenotype
  • Abstract Number: 198
    CL-L1 and CL-K1 Complement Associated Pattern Recognition Molecules in Systemic Lupus Erythematosus
  • Abstract Number: 1174
    Class 3 Semaphorins Modulate the Invasive Capacity of Rheumatoid Arthritis Fibroblast-like Synoviocytes
  • Abstract Number: 421
    Clinical Analysis and Outcome of Interstitial Lung Disease with Juvenile Dermatomyositis
  • Abstract Number: 1538
    Clinical Analysis of 30 Rheumatoid Arthritis Patients Complicated with Malignant Lymphoma, Especially Methotrexate-Related Lymphoproliferative Disorder
  • Abstract Number: 2183
    Clinical and Epidemiological Correlates of the Adjusted Global Anti-Phospholipid Syndrome Score in a Large Cohort of Chinese APS Patients
  • Abstract Number: 2452
    Clinical and Functional Outcomes in Patients with Polyarticular Juvenile Idiopathic Arthritis Following Treatment with Adalimumab
  • Abstract Number: 221
    Clinical and Genetic Characteristics of Diuretic-Associated Gout: A Case-Control Study
  • Abstract Number: 713
    Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 104-Week Treatment Results
  • Abstract Number: 693
    Clinical and Imaging Features of Reactive Arthritis in Guatemala City
  • Abstract Number: 766
    Clinical and Immunological Characteristics of 150 Systemic Lupus Erythematosus Patients in Urban Jamaica
  • Abstract Number: 2729
    Clinical and Radiographic Outcome of Iguratimod for Rheumatoid Arthritis
  • Abstract Number: 389
    Clinical and Serological Differences Between Juvenile-Onset and Adult-Onset Systemic LUPUS Erythematosus Patients from a National Registry of Patients
  • Abstract Number: 398
    Clinical and Serological Profile of Children with Positive SSA-Ro/SSB-La Antibodies
  • Abstract Number: 1382
    Clinical and Serum IgG4 Characteristics of a Unique British Columbian IgG4-Related Disease Cohort
  • Abstract Number: 468
    Clinical and Ultrasonographic Inflammation in DMARD-Naïve Early Rheumatoid Arthritis (RA) – Impact of the 2010 ACR/EULAR Classification Criteria Versus the 1987 ACR Classification Criteria
  • Abstract Number: 1636
    Clinical Benefit of 1-Year Certolizumab Pegol Treatment in MTX-Naïve, Early Rheumatoid Arthritis Patients Is Maintained after Discontinuation up to 1 Year
  • Abstract Number: 678
    Clinical Characteristics and Disease Activity in Psoriatic Arthritis Patients with Dactylitis or Enthesitis: Results from Corrona Registry
  • Abstract Number: 3118
    Clinical Characteristics and Disease Outcomes in Psoriatic Arthritis Patients By Extent of Body Surface Area Affected By Psoriasis: Results from Corrona Registry
  • Abstract Number: 2667
    Clinical Characteristics and Health Outcomes of RA Patients Not Adequately Controlled By Current Treatment
  • Abstract Number: 1559
    Clinical Characteristics and Medication Use Among Arab Patients with Rheumatoid Arthritis in Some Arab States
  • Abstract Number: 1348
    Clinical Characteristics and Outcomes of Patients with Septic Arthritis Treated without Surgery
  • Abstract Number: 2035
    Clinical Characteristics and Outcomes of Polyarticular Septic Arthritis
  • Abstract Number: 1349
    Clinical Characteristics and Outcomes of Septic Bursitis
  • Abstract Number: 1785
    Clinical Characteristics and Relative Factors of Infections in Southern Chinese Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2370
    Clinical Characteristics of Anti-MDA5 (+) Dermatomyositis Patients in North America
  • Abstract Number: 1749
    Clinical Characteristics of Axial Spondyloarthritis Patients Progressing from Non-Diagnostic to Diagnostic Radiographic Sacroiliitis
  • Abstract Number: 74
    Clinical Characteristics of Fibromyalgia in a Chronic Pain Population
  • Abstract Number: 1599
    Clinical Characteristics of Interstitial Lung Disease (ILD) in Rheumatoid Arthritis (RA) Patients in High Resolutional CT (HRCT) and Titer of Anti Citrullinated Peptide Antibodies (anti-CCP2)
  • Abstract Number: 674
    Clinical Characteristics of Japanese Patients with Reactive Arthritis Induced By Intravesical BCG Therapy for Bladder Cancer: A 19 Years Two-Center Retrospective Study
  • Abstract Number: 440
    Clinical Characteristics of Rheumatoid Arthritis Patients Achieving HAQ Remission with 6 Months of Biologic Treatment
  • Abstract Number: 1394
    Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study
  • Abstract Number: 2256
    Clinical Characteristics, Laboratory Findings and Nailfold Capillaroscopy Microscopy Patterns in a Monocentric Series of 123 Patients with Idiopathic Pernio
  • Abstract Number: 1562
    Clinical Correlates, Outcomes and Predictors of Episcleritis and Scleritis Associated with Rheumatoid Arthritis
  • Abstract Number: 476
    Clinical Disease Activity Measures Change Substantially and Irregularly over Time in Individual Rheumatoid Arthritis Patients Considered to be in Steady State
  • Abstract Number: 1986
    Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An OPEN-Label Study.
  • Abstract Number: 773
    Clinical Evaluation of Patients with Positive Antibodies to Extractable Nuclear Antigens but Negative ANA
  • Abstract Number: 2438
    Clinical Examination of the Temporomandibular Joint; A Eurotmjoint Initiative
  • Abstract Number: 466
    Clinical Factors, Anti-Citrullinated Peptide Antibodies and MRI-Detected Subclinical Inflammation in Relation to Progression from Clinically Suspect Arthralgia to Arthritis
  • Abstract Number: 3066
    Clinical Features and Treatments of Takayasu Arteritis Complicated with Ulcerative Colitis
  • Abstract Number: 2376
    Clinical Features in Dermatomyositis Patients with Novel Autoantibody to Small Ubiquitin-like Modifier Activating Enzymes (Anti-SAE Antibody) and Relationship to Interstitial Lung Disease: A Systematic Review of 29 Cases
  • Abstract Number: 394
    Clinical Features of Children with Silent Lupus Nephritis
  • Abstract Number: 154
    Clinical Features of Fibromyalgia in Patients with Rheumatoid Arthritis Predict Lower Power Doppler Scores on Ultrasound
  • Abstract Number: 2379
    Clinical Follow-up Predictors of Disease Pattern Change in Anti Jo-1 Positive Antisynthetase Syndrome: Results from a Multicenter, International and Retrospective Study
  • Abstract Number: 688
    Clinical Improvements in Psoriasis and Psoriatic Arthritis with Surgical Weight Loss
  • Abstract Number: 765
    Clinical Improvements in Systemic Lupus Erthematosus Are Correlated to Cellular and Soluble Biomarkers in Classical Complement Pathway
  • Abstract Number: 2033
    Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection
  • Abstract Number: 1639
    Clinical Outcomes for Rheumatoid Arthritis Patients Receiving Tofacitinib Monotherapy in the Open-Label Long-Term Extension over 6 Years
  • Abstract Number: 467
    Clinical Outcomes of Patients with Active Rheumatoid Arthritis with Normal Acute-Phase Reactant Values
  • Abstract Number: 1667
    Clinical Parameters and B Cell Subsets As Biomarkers of Response to Tocilizumab in Rheumatoid Arthritis
  • Abstract Number: 264
    Clinical Phenotype and Response to Treatment in Adult-Onset Still’s Disease with MEFV Variants
  • Abstract Number: 3197
    Clinical Practice Experience in Rheumatoid Arthritis Patients Treated with Triple Therapy and Methotrexate-Tumor Necrosis Factor Inhibition Differs from That of Randomized Controlled Trials
  • Abstract Number: 2487
    Clinical Practices Participating in a Quality Improvement Project Make Progress in Implementing Population Management
  • Abstract Number: 540
    Clinical Relevance of Etanercept Levels and Anti-Etanercept Antibodies in Long-Term Treatment of Rheumatoid Arthritis Patients
  • Abstract Number: 653
    Clinical Responses and Improvements in Patient-Reported Outcomes Are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol
  • Abstract Number: 2860
    Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes Are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
  • Abstract Number: 2687
    Clinical Significance of Patient-Reported Pain and Stiffness at Each Joint Level  in the Evaluation of Patients with Rheumatoid Arthritis
  • Abstract Number: 627
    Clinical Subsets and Presenting Features in Primary Sjögren’s Syndrome: Results from a Single Center Inception Cohort Study
  • Abstract Number: 2619
    Clinical Usefulness of Periodic Detection of Serum 14-3-3η for Predicting Efficacy of Tocilizumab in RA
  • Abstract Number: 2758
    Clinical Utility and Factors Associated with Certolizumab Pegol Drug Levels and Anti-Drug Antibodies in the Long-Term Treatment of Rheumatoid Arthritis
  • Abstract Number: 1317
    Clinical Utility of Joint Space Width and X-Ray Radiogrammetry in RA: Markers for Early Radiographic Progression
  • Abstract Number: 842
    Clinical Utility of Serial KL-6 Measurement in Interstitial Lung Disease Associated with Systemic Sclerosis
  • Abstract Number: 2304
    Clinical, Ultrasonographic and Neurophysiological Correlation of Patients with Carpal Tunnel Syndrome in Santo Domingo, Dominican Republic
  • Abstract Number: 2655
    Clinically Important Worsening (CIW) of RA Disease Activity Requiring an Increase in Therapy Can be Identified Using a Combined Patient and Physician Report of Flare
  • Abstract Number: 871
    Clinicians’ Perspective on Aspects of ANCA-Associated Vasculitis That Influence Patients’ Function and General Health: A Delphi Exercise Based on the International Classification of Function, Disability and Health
  • Abstract Number: 1450
    Clostridium Difficile Infection-Associated Reactive Arthritis in a Pediatric Cohort
  • Abstract Number: 1109
    Co-Crystal Structure of TACI and APRIL-BAFF-BAFF Heteromer Suggests That Charged Residues in APRIL and BAFF Dictate Their Receptor Binding Affinities
  • Abstract Number: 2802
    Co-Occurence of Anti-Ro52/TRIM21 and Anti-TRIM38 Autoantibodies Is Associated with Higher Severity of Dry Eye in Sjögren’s Syndrome
  • Abstract Number: 91
    Coevolution of a Uric Acid Transporter and Uricase: Implications for Gout
  • Abstract Number: 1408
    Cogan Syndrome: Differential Response to Biologic Agents and Role of PET-CT in the Increased Diagnosis of Aortitis
  • Abstract Number: 3049
    Cognitive Dysfunction in Chronic Progressive Neuro-Behçet’s Disease: Comparative Study of the Brainstem and Hippocampus Region Using Brain Magnetic Resonance Imaging
  • Abstract Number: 2955
    Cognitive Impairment in Lupus Patients: Identification of the Best Screening Test and Assessment for Associated Factors
  • Abstract Number: 947
    Cohesin Complex Is a New Myositis Autoantigen
  • Abstract Number: 3007
    Cold Receptor Expression and Function in Human Dermal Fibroblast: Possible Role in the Pathogenesis of Scleroderma Fibrosis
  • Abstract Number: 1016
    Collagen Antibodies Induce Pain-like Behavior in Mice Independent of Inflammation and Complement Activation but Requires Fcγrs
  • Abstract Number: 1153
    Colonic Intraepithelial Lymphocytes Produce IL-6 in Response to Resident Bacteria to Modulate Epithelial Barrier Function
  • Abstract Number: 1959
    Color Doppler Ultrasonography Appears to Perform Better Than Magnetic Resonance Angiography in the Diagnostics of Patients with Systemic Large Vessel Vasculitis
  • Abstract Number: 1957
    Colour-Doppler Ultrasonography of Epiaortic Arteries in Patients with Giant Cell Arteritis
  • Abstract Number: 3171
    Combination Therapy with Denosumab and Biologic DMARD Associated with Higher Risk of Serious Infections Compared to Denosumab Alone and Biologic DMARD Alone
  • Abstract Number: 2917
    Combined Proliferative and Membranous Lupus Nephritis: Is the Prognosis Really Poor?
  • Abstract Number: 1707
    Comorbidity Burden and Medication Use Among Patients with Psoriatic Arthritis in the US
  • Abstract Number: 2557
    Comparable Therapeutic Potential of Umbilical Cord Mesenchymal Stem Cells in Collagen Induced Arthritis with Anti-Tumor Necrosis Factor or Anti-CD20
  • Abstract Number: 480
    Comparative 10-Year Retention Rates of Adalimumab Used in Mono and Combination Therapy in Rheumatoid Arthritis (RA) Patients from the Rhumadata Clinical Database and Registry
  • Abstract Number: 2570
    Comparative Analysis of Collagen-Antibody Induced Arthritis and the  Arthritis Inhibitory Potential of Specific ACPA in Two Mouse Subspecies Genetically Separated about One Million Years Ago
  • Abstract Number: 2767
    Comparative Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated By Serum Amyloid a
  • Abstract Number: 505
    Comparative Effectiveness and Time to Response Among Abatacept, Adalimumab, Certolizumab, Etanercept, Infliximab, Rituximab and Tocilizumab in a Real World Routine Care Registry
  • Abstract Number: 951
    Comparative Effectiveness of Tai Chi Versus Physical Therapy in Treating Knee Osteoarthritis: A Randomized, Single-Blind Trial
  • Abstract Number: 1781
    Comparative Efficacy and Safety of Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide As Induction Therapy for Lupus Nephritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
  • Abstract Number: 3160
    Comparative Rates of Serious Infections and All-Cause Mortality Among Systemic Lupus Erythematosus Patients Receiving Mycophenolate Mofetil Versus Azathioprine
  • Abstract Number: 2175
    Comparative Study Between Coagucheck XS Versus Standard Laboratory Practice Protrombine Time for Monitoring Anticoagulant Therapy in Patients with Antiphospholipid Syndrome   
  • Abstract Number: 1486
    Comparative Study of Instruments to Assess Disease Activity in Fibrolyalgia
  • Abstract Number: 373
    Compared to Non-Users, Current Glucocorticoids Users Have Less Prevalent Fractures at the Same Bone Mass: Results of a Large Cross-Sectional Study
  • Abstract Number: 2693
    Comparing Eight Year Clinical and Radiographic Outcome in Two Cohorts of Patients with Rheumatoid Arthritis
  • Abstract Number: 311
    Comparison Between Intra Articular Ozone and Placebo in the Treatment of Knee Osteoarthritis: A Multicentric, Comparative, Randomized and Double-Blinded Clinical Trial
  • Abstract Number: 1300
    Comparison Between Semiquantitative and Quantitative Methods for the Assessment of Knee Synovitis Using Non-Enhanced and Gadolinium-Enhanced MRI
  • Abstract Number: 349
    Comparison Between the American Recommendations and the Japanese Guidelines for Glucocorticoid-Induced Osteoporosis in Japanese Patients with Rheumatoid Arthritis
  • Abstract Number: 1548
    Comparison of 5 Cardiovascular Risk Calculators in a Hispanic Rheumatoid Arthritis Cohort
  • Abstract Number: 2636
    Comparison of Arterial Health in Patients with Rheumatoid Arthritis to a Population-Based Cohort
  • Abstract Number: 192
    Comparison of Bone Scan with Xiralite (FOI) in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
  • Abstract Number: 548
    Comparison of Dose Escalation and Co-Therapy Intensification Between Patients with Rheumatoid Arthritis Initiating Biologic Treatment with Etanercept, Adalimumab and Infliximab
  • Abstract Number: 1819
    Comparison of Electrocardiographic ST-T Changes and QTc Duration in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
  • Abstract Number: 1280
    Comparison of Health Service Utilization Costs Between Aboriginal and Non-Aboriginal Patients with Rheumatoid Arthritis Requiring Biologic Therapy
  • Abstract Number: 1384
    Comparison of IgG4-Related and Non-IgG4-Related Retroperitoneal Fibrosis; A 12 Year Retrospective Study
  • Abstract Number: 2142
    Comparison of Interferon-y Release Assay Versus Tuberculin Skin Test in the Golimumab UC and the Golimumab SC Rheumatology (RA, PsA, and AS) Clinical Study Programs
  • Abstract Number: 1478
    Comparison of JIA and RA Patients in the National Data Bank for Rheumatic Diseases
  • Abstract Number: 2407
    Comparison of Knee Osteoarthritis Treatment in the Non-Obese Versus Obese Populations Across Different Medical Specialties
  • Abstract Number: 2670
    Comparison of M-DAS and DAS28, Two Composite Scores for Prediction of Structural Damages in Rheumatoid Arthritis: Data from the Espoir Cohort
  • Abstract Number: 1651
    Comparison of Oral Glucocorticoid (OGC)-Sparing Effects in Tocilizumab and Other Biologic Dmards Using Multilevel Models in an Administrative Health Care Claims Database
  • Abstract Number: 667
    Comparison of Patient and Provider Assessments of Response to Therapy for Psoriatic Arthritis
  • Abstract Number: 1545
    Comparison of Statin Eligibility According to the Adult Treatment Panel III, ACC/AHA Blood Cholesterol Guideline and Presence of Carotid Plaque By Ultrasound in Hispanics with Rheumatoid Arthritis
  • Abstract Number: 1414
    Comparison of Surgical and Conservative Therapy of Lumbar Disc Herniation with Radicular Signs and Symptoms in a Quality Management Program
  • Abstract Number: 2402
    Comparison of Synovitis on MRI and Pain in Knee Osteoarthritis Patients with and without Chondrocalcinosis: Data from the Osteoarthritis Initiative (OAI)
  • Abstract Number: 748
    Comparison of Systemic Lupus Erythematosus in 3 Different Asian Ethnic Groups: Results from the 1000 Faces of Lupus Cohort
  • Abstract Number: 660
    Comparison of the Four Validated Psoriatic Arthritis Screening Tools in Diagnosing Psoriatic Arthritis in Patients with Psoriasis [Compaq Study]
  • Abstract Number: 438
    Comparison of the Stanford and Indian Health Assessment Questionnaires for Disability Outcomes in a Phase 3, Randomized, Double-Blind, Active Comparator Study of Infliximab and Biosimilar Infliximab BOW15 in Rheumatoid Arthritis
  • Abstract Number: 2746
    Comparison Study of Tests Available to Monitor Tocilizumab Therapy in Rheumatic Patients
  • Abstract Number: 736
    Complement Activation As a Marker for Increased Thrombosis Risk in SLE Patients with Antiphospholipid Antibodies
  • Abstract Number: 1996
    Complement Activation Predicts Adverse Pregnancy Outcome in Patients with SLE and/or aPL Antibodies
  • Abstract Number: 1371
    Complement-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?  
  • Abstract Number: 2242
    Compliance with Allopurinol Among Hypertensive Patients with Gout Diagnosis and the Relationship to Onset of End-Stage Renal Disease
  • Abstract Number: 30
    Complications of Inflammatory Arthritis in First Nations and Non-First Nations Populations of Alberta, Canada
  • Abstract Number: 447
    Components of Treatment Delay in Rheumatoid Arthritis Differ According to Autoantibody Status
  • Abstract Number: 1188
    Comprehensive Musculoskeletal Course Improves Post-Graduate Trainees’ Confidence in Performing Joint Injections
  • Abstract Number: 1187
    Comprehensive Musculoskeletal Exam Curriculum for Rheumatology Fellows
  • Abstract Number: 1152
    Comprehensive Novel Proteomic Analysis of RA Synovial Fluid Highlights the Distinct Protein Profiles of Bone and Cartilage Metabolism
  • Abstract Number: 1734
    Computer Aided Syndesmophyte Measurement on Spinal Radiographs in Axial Spondyloarthritis Patients
  • Abstract Number: 2912
    Concomitant Kidney Disease in Patients with Lupus Nephritis
  • Abstract Number: 2573
    Confirmatory Analysis of Methylome Signatures in Rheumatoid Arthritis Using an Independent Dataset
  • Abstract Number: 176
    Considerable Discrepancy Between Patient’s Assessment and Ultrasonography Assessment on the Most Affected Joint in Rheumatoid Arthritis
  • Abstract Number: 2737
    Consistency of Treatment Effects Across Different High-Risk Clinical Phenotypes in the Tofacitinib Clinical Program
  • Abstract Number: 2263
    Construct and Convergent Validity of Four Global Measures of at-Work Productivity Loss in Patients with Rheumatic Diseases
  • Abstract Number: 665
    Construct Validity of Disease Activity for Psoriatic Arthritis Composite Index and Tentative Cut-Off Values in a Cohort of Patients with Psoriatic Arthritis
  • Abstract Number: 341
    Construct Validity of Four Hand Mobility Measures in Hand Osteoarthritis (HOA)
  • Abstract Number: 337
    Construct Validity of the Doyle Index in the Outcome Domain of Joint Activity in Hand Osteoarthritis Patients
  • Abstract Number: 2540
    Construct Validity of the Promis-29 in Systemic Sclerosis: Results from the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort
  • Abstract Number: 2543
    Content Validity of the Improved Health Assessment Questionnaire in Knee Osteoarthritis Patients
  • Abstract Number: 978
    Continuous Versus on Demand Treatment of Ankylosing Spondylitis with Diclofenac over 2 Years Does Not Prevent Radiographic Progression of the Spine: Results from a Randomized Prospective Multi-Center Trial
  • Abstract Number: 2513
    Contraception Use Amongst Women Ages 18-45 Taking Known Teratogenic Medications in an Academic Rheumatology Clinic
  • Abstract Number: 2028
    Contribution of 18f-Fluoro-Dexoxyglucose Positron Emission Tomography for the Diagnosis of Polymyalgia Rheumatica: A Controlled Study
  • Abstract Number: 863
    Contribution of MPO-/PR3-ANCA Tests to the Diagnosis of ANCA-Associated Vasculitis in a Community Hospital: Evaluation of 2,782 Samples
  • Abstract Number: 2683
    Contribution of Subjective Patient Reported Components of Disease Activity Scores Differs in Disease Activity Measures and Their Changes over Time Are Closely Associated with Objective Measures
  • Abstract Number: 1015
    Contribution of TNF and Type I Interferon to the Development of Persistent Post-Inflammatory Mechanical Allodynia in Arthritic Mice
  • Abstract Number: 45
    Contributions of Social Determinants of Health on Probability of Remission in Early and Established Rheumatoid Arthritis Patients
  • Abstract Number: 2413
    Contributors to Walking Disability in People with Osteoarthritis: Results from a Population-Based Cohort
  • Abstract Number: 1539
    Control of Modifiable Cardiovascular Risk Factors in Rheumatoid Arthritis Patients Compared to Traditional High-Risk Cardiovascular Disease Patients
  • Abstract Number: 656
    Convergent Construct Validity of PsAID12 in a Psoriatic Arthritis Cohort at Baseline
  • Abstract Number: 771
    Convergent Validity of New Disease Assessment Instruments in Systemic Lupus Erythematosus in Relation to Sledai-2K
  • Abstract Number: 3270
    Correction of Limb Length Inequality in Adults with Knee or Hip Symptoms: A Pilot Study
  • Abstract Number: 175
    Correlating Semiquantitative Ultrasound Scores with Measured Synovial Thickness
  • Abstract Number: 613
    Correlation Between Efficacy of Tocilizumab and Levels of Oxidative Stress Markers in Patients with Rheumatoid Arthritis: the 52-Week Analysis
  • Abstract Number: 2286
    Correlation of Magnesium Levels and IGF-! Levels in Fibromyalgia Patients
  • Abstract Number: 1522
    Correlation of Oxidized Low Density Lipoprotein Levels with Carotid Intima Media Thickness in Rheumatoid Arthritis Patients
  • Abstract Number: 2708
    Correlation of Peripheral Blood Th-17 and Th-1 with Synovitis and Osteitis By MRI in Recent Onset Rheumatoid Arthritis
  • Abstract Number: 2641
    Correlation of Rheumatologists’ Perceptions of RA Severity with Observed Disease Activity, Patient Impact and Treatment Patterns
  • Abstract Number: 1895
    Correlation of Scleroderma Interstitial Lung Disease with Gastroesophageal Reflux
  • Abstract Number: 492
    Correlations Between Clinical, Laboratory and Ultrasound Joint Examination in RA Patients Treated with Rituximab
  • Abstract Number: 2963
    Correlations Between Microvasculature Changes and Angiogenic Factors in Systemic Sclerosis – Data from a Single Center Registry
  • Abstract Number: 291
    Correlations Between Muscle-MRI, Muscle Strength and Creatine Kinase Levels in the Anti-Synthetase Syndrome; A Comparative, Cross-Sectional Study
  • Abstract Number: 2647
    Correlations Between Personality Types, Disease Activity and Quality of Life in As and RA Patients
  • Abstract Number: 1976
    Corticosteroid Therapy in Giant Cell Arteritis, Predictors for Long-Term Remission
  • Abstract Number: 1990
    Corticosteroid Use in Idiopathic Aortitis: A Systematic Review
  • Abstract Number: 1271
    Cost Savings and Interest in Pediatric Rheumatology Telemedicine Visits
  • Abstract Number: 366
    Cost-Effective Osteoporosis Treatment Intervention Thresholds Based on FRAX in Portugal
  • Abstract Number: 952
    Cost-Effectiveness of Opioids for the Treatment of Knee Osteoarthritis: Impact of Chronic Opioid Use on Total Knee Arthroplasty Outcomes
  • Abstract Number: 2137
    Critical Role of Fibroblast-like Synoviocytes Glycolytic Metabolism in Rheumatoid Arthritis
  • Abstract Number: 1689
    Cross Sectional Study Investigating the Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis
  • Abstract Number: 82
    Cross-Sectional Analysis of Heart Rate Variability in Patients with Fibromyalgia (FM): Correlations with Baseline Clinical Measures
  • Abstract Number: 2045
    Cross-Validation of the Pediatric Automated Neuropsychological Assessment Metrics-Cognitive Performance Scores in the Screening of Neurocognitive Impairment in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 1169
    Crossregulatory Mechanisms Between Synovial Fibroblasts and Macrophages Relevant in RA Pathogenesis
  • Abstract Number: 2587
    CRP and 14-3-3η Are Each Associated with Joint Damage Progression, Their Titres Do Not Correlate and Are Better Predictors of Progression Together Than Alone
  • Abstract Number: 2720
    Crucial Role of Nuclear Factor of Activated T Cell 5 (NFAT5), an Osmo-Protective Factor, in Migration and Invasion of Rheumatoid Synoviocytes
  • Abstract Number: 965
    Crystal Structure of Porphyromonas Gingivalis peptidylarginine Deiminase: Implications for Autoimmunity in Rheumatoid Arthritis
  • Abstract Number: 513
    Cumulative Association of Genetic Variants with Rheumatoid Joint Damage Progression in Mexican Americans and European Americans
  • Abstract Number: 2283
    Current and Lifetime Smoking Among US Adults with Arthritis: A Serious Clinical and Public Health Issue
  • Abstract Number: 696
    Current and Past Smoking Are Associated with Functional Impairement and Increased Disease Activity in Axial Spondyloarthritis: Systematic Review and Meta-Analysis
  • Abstract Number: 391
    Current Provider Practices and Perceived Barriers for Mental Health Care of Adolescents with SLE
  • Abstract Number: 3211
    Current Smoking, Its Intensity and Duration, Is Associated with Fat Metaplasia on MRI in Patients with Spondyloarthritis
  • Abstract Number: 1425
    Current Tobacco Use and the Rates of Complications after Total Hip Arthroplasty
  • Abstract Number: 2251
    Current Tobacco Use and the Rates of Postoperative Complications after Total Knee Arthroplasty
  • Abstract Number: 2834
    CXCL10 Expression Is Elevated in Synovial Fluid of Psoriatic Arthritis Patients
  • Abstract Number: 1078
    CXCL4 Does Not Predict Extent or Progression of Interstitial Lung Disease in Systemic Sclerosis
  • Abstract Number: 2722
    Cyclic Phosphatidic Acid (CPA) Suppresses Expression of Cartilage Degrading Enzymes Such As MMP-3, MMP-13 and Adamts-4 in Inflammatory Synovial Fibroblasts and Articular Chondrocytes Induced By IL-1 Beta and/or TNF ALFA
  • Abstract Number: 1818
    Cyclophosphamide and Cumulative Steroid Dose Associated with Higher Risk of Infections in Patients with Lupus Nephritis
  • Abstract Number: 2926
    Cytochrome P450 Polymorphisms on Blood Hydroxychloroquine Levels in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 3
    Cytokine Production Patterns in Osteoporosis Suggest a Pro-Inflammatory Bias
  • Abstract Number: 2465
    Cytokine Profile Comparison of Monogenic and Complex Conditions with Interferon-Regulated Gene Signatures in Chronic Atypical Neutrophilic Dermatosis with Lipodsytrophy and Elevated Temperature (CANDLE), SAVI, Aicardi-Goutieres Syndrome, JDM, and SLE
  • Abstract Number: 2812
    Cytokine Secretion By Peripheral Blood Mononuclear Cells in Patients with Axial Spondyloarthritis and the Effect of Thymoquinone on Cytokine Profile
  • Abstract Number: 1357
    Cytomegalovirus (CMV) Infections in Patients with Rheumatic Diseases: Experience of a Referral Center
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.